Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Open accessThe DOI matches its Crossref record; 304 of the 332 references it cites were found in a registry or an index, and 21 are not checked yet; 105 of the 438 sources its claims cite were checked for support.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in the management of obesity; however, their efficacy and tolerability may be further optimized through complementary nutritional strategies. Such interventions may address key challenges associated with GLP-1RA therapy, including gastrointestinal adverse effects, lean mass loss, and reduced long-term adherence leading to weight regain. Evidence from preclinical and clinical studies indicates that omega-3 polyunsaturated fatty acids may enhance the metabolic benefits of GLP-1RAs and attenuate lean mass loss, primarily via anti-inflammatory pathways and modulation of protein synthesis. Synergistic effects have also been reported with other bioactive compounds—such as flavonoids and anthocyanins, which improve metabolic outcomes; probiotics and prebiotics, which may alleviate gastrointestinal intolerance; and high-quality protein sources, which support body composition preservation. Collectively, these findings suggest that nutritional adjuncts may complement GLP-1RA therapies through convergent physiological mechanisms, including the regulation of inflammation, gut microbiome composition, and cellular metabolism. While current data highlight the promise of integrated pharmaco-nutritional strategies as adjuncts to GLP-1-based obesity therapy, further randomized controlled trials are needed to establish the most effective interventions and protocols.
Verified 2026-11-19 · 21 references not checked yet
Overview
CoChat Summary
TL;DR
This narrative review argues that nutritional adjuncts—fiber/prebiotics, probiotics, protein sources, specific nutrients, and botanical actives—may complement GLP-1 receptor agonist (GLP-1RA) therapy in obesity by improving GI tolerability, preserving lean mass, and amplifying metabolic benefits. However, direct clinical evidence combining these interventions with GLP-1RAs remains scarce, and most proposed synergies are based on indirect, preclinical, or expert-consensus evidence.
Key findings
- GLP-1RAs achieve placebo-adjusted weight loss of 8–21% after one year, but long-term effectiveness is limited by GI adverse events affecting up to 70–85% of patients, nutritional deficiencies, lean mass loss, and weight regain—with up to two-thirds of lost weight returning within one year after discontinuation.
- Nutritional adjuncts with the strongest practice-reasonable support include adequate protein intake, ginger, dietary fiber, and probiotics for preserving lean mass and improving GI tolerability; expert consensus recommends fiber for constipation and probiotics for persistent diarrhea during GLP-1RA treatment.
- Specific evidence cited includes a pilot study of 27 obese patients where a multispecies probiotic plus low-dose liraglutide produced comparable weight loss to higher-dose liraglutide alone, with 59.3% reporting only mild transient GI symptoms and none discontinuing, versus an 80.3% adverse-event incidence in a comparable high-dose liraglutide trial.
- Other reported findings include L. gasseri BNR17 producing a ~22 cm² decrease in visceral adiposity versus placebo; oral glutamine (15 g/day) achieving ≥50-point IBS severity score reduction in 79.6% vs 5.8% with placebo; and omega-3/krill oil trials showing muscle function or lean-mass benefits, though omega-3 evidence is described as mixed.
Methods
- Narrative review with a targeted, non-systematic search in PubMed, Scopus, Google Scholar, and Cochrane up to September 2025, plus manual reference searching.
- Search terms included “GLP-1,” “GLP-1 receptor agonists,” drug names (semaglutide, liraglutide, tirzepatide), intervention descriptors (“nutrition,” “dietary interventions,” “nutraceuticals”), and specific actives (“probiotics,” “fibers,” “botanical extracts”).
- The review prioritized English-language clinical and preclinical studies reporting metabolic and/or GI tolerability outcomes relevant to GLP-1RA therapy, synthesizing preclinical, indirect clinical, and direct clinical findings when available.
Limitations
- The paper states that direct clinical evidence combining nutritional interventions with GLP-1RAs remains limited, that many compounds have not been studied in combination with GLP-1RAs, and that further randomized controlled trials are needed to establish effective interventions and protocols.
- The paper notes that nutritional supplements differ from pharmacological agents in regulatory classification and are not subject to the same pre-market clinical validation, and advises caution in vulnerable populations such as pregnant/lactating women, older adults, critically ill patients, and those with hepatic or renal impairment.
- Evident from the text: the search was non-systematic, with no described protocol, risk-of-bias assessment, or formal evidence grading; many proposed benefits rely on preclinical data, studies in non-GLP-1RA populations, or expert consensus, so several adjunctive roles remain hypothetical.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
24 Valid · 41 Not valid · 244 Not checked · 59 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A meta-analysis of 16 randomized controlled trials with 1251 adults with chronic constipation showed that fiber, particularly psyllium at doses >10 g/day for ≥4 weeks, significantly improved stool frequency and consistency [132]”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.1. Dietary Fibers and Prebiotics
What the sources say
- Disputedcites [132] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a causen = 1,251- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A meta-analysis of 37 randomized controlled trials confirmed that higher protein intake reduced body weight by ~1.6 kg, with prediabetic subjects benefiting the most [163].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.3. Protein Sources
What the sources say
- Disputedcites [163] sourceExperimental — accuracy not yet measured
The Results (Characteristics of included studies; page unavailable) state that this meta-analysis included 22 studies, not 37. The paper reports glycemic and lipid outcomes, but does not report the claimed ~1.6 kg reduction in body weight or a greatest benefit among prediabetic subjects. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In older adults, >2 g/day was associated with modest gains in muscle mass (0.67 kg) and improvements in walking speed, particularly after interventions > 6 months (1.78 m/s; 95% CI: 1.38-2.17)[190].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.4.4. Omega-3 Polyunsaturated Fatty Acids
What the sources say
- Disputedcites [190] sourceExperimental — accuracy not yet measured
The Results (Eligible studies and baseline characteristics; page unavailable) state that treatment lasted 3–24 weeks, contrary to the claim of an effect particularly after interventions longer than six months. The Methods (Statistical analysis; page unavailable) identify weight, BMI, waist circumference, lipids, and glucose as outcomes; the paper does not report the claimed walking-speed estimate or muscle-mass gain in older adults. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Another randomized controlled trial with 41 overweight/obese adults undergoing an alternate-day fasting regimen showed that KO (4 g/day, SuperbaBoost™, Aker BioMarine ASA, Lysaker, Norway) for 8 weeks attenuated declines in fat-free mass (-0.2 ± 0.9 kg) and handgrip strength (-0.2 ± 0.5 kg) observed in the placebo group [308].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.4.4. Omega-3 Polyunsaturated Fatty Acids
What the sources say
- Disputedcites [308] sourceExperimental — accuracy not yet measured
The Methods (Study population and Intervention; page not provided) describe a 28-day krill-oil study in healthy young adults, with 17 included in the analysis; obesity was an exclusion criterion. Participants were advised to maintain their body weight, not undergo alternate-day fasting. The cited paper therefore describes a different study and does not report the claimed placebo comparison or fat-free-mass and handgrip outcomes. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In metabolic syndrome, pine bark extract (150 mg/day, for 6 months) improved key risk factors: it lowered fasting glucose (~123 to ~105 mg/dL), reduced waist circumference (-7.9 cm in men and -7.3 cm in women), increased adiponectin, and reduced blood pressure and oxidative stress markers [213].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.5.4. French Maritime Pine (Pinus pinaster) Bark Extract
What the sources say
- Disputedcites [213] sourceExperimental — accuracy not yet measured
Table 2 and §3.2 report fasting-glucose results for Guava Leaf Tea, not pine bark extract: 136 to 131 mg/dL after 12 weeks in pre-diabetic and mildly diabetic subjects. The cited paper does not report the claimed 150 mg/day, six-month pine-bark regimen or the change from approximately 123 to 105 mg/dL. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
210 more claims · 42 with their cited sources checked
Create a free account to see all 368 claims and to verify the 333 references still open.
- It may state two separate claims as one. 138
- Probably not a substantial claim. 20
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, distributing protein intake evenly across meals has been found to be particularly effective, as it maximizes muscle protein synthesis throughout the day [72].”
From A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass (2026) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because dietary lipids act synergistically with GLP-1 to inhibit gastric emptying, reducing fat load per meal is a physiologically plausible and commonly recommended strategy to reduce postprandial nausea and fullness during GLP-1 RA titration, although randomized dietary-modification trials specifically in GLP-1-treated cohorts are lacking [66,67].”
From Adherence and Persistence with GLP-1-Based Therapies: International Real-World Evidence and the Role of Nutritional and Lifestyle Support—A Narrative Review (2026) · cites this paper as [67]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.4.3. Zinc
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > References
“Thoen, R.U.; Barther, N.N.; Schemitt, E.; Bona, S.; Fernandes, S.; Coral, G.; Marroni, N.P.; Tovo, C.; Guedes, R.P.; Porawski, M. Zinc supplementation reduces diet-induced obesity and improves insulin sensitivity in rats.”
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00933-4 · Cited by 2,884
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · cited 3×
“…insulin secretion from pancreatic β -cells [32], stimulates somatostatin secretion from δ -cells, which suppresses glucagon secretion from α -cells [31], and exerts cytoprotective effects on β -cells by inhibiting apoptosis, inducing proliferation, and supporting insulin biosynthesis [31,36].”
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444
Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)
Mao, Q.-Q., Xu, X.-Y., Cao, S.-Y., Gan, R.-Y., Corke, H., Beta, T., & Li, H.-B. (2019) · Foods · doi:10.3390/foods8060185 · Cited by 1,418 · cited 1×
“Its active compounds (gingerols and shogaols) act through multiple mechanisms: antagonism of 5-HT3 receptors, vagal modulation, and acceleration of gastric emptying [225–228].”
Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14725 · Cited by 1,128 · cited 1×
“Although GLP-1RAs induce substantial weight loss and metabolic improvements, their long-term effectiveness is limited by challenges such as weight regain after discontinuation, with up to two-thirds of the lost weight returning within one year [56–58].”
Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O’Neil, P. M., Rubino, D. M., Skovgaard, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.1831 · Cited by 1,114 · cited 1×
“Complementary nutritional interventions are therefore crucial for the long-term success of GLP-1RA therapy, with studies showing that nutritional counselling improves results and adherence through individualized guidance and management of adverse effects [27–30].”
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036 · cited 3×
“Structural modifications of the GLP-1 molecule led to the development of GLP-1RAs with prolonged half-life, enabling sustained glycemic control and weight reduction [33,38,40].”
Dietary fibre in gastrointestinal health and disease
Gill, S. K., Rossi, M., Bajka, B., & Whelan, K. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00375-4 · Cited by 979
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
Portincasa, P., Bonfrate, L., Vacca, M., De Angelis, M., Farella, I., Lanza, E., Khalil, M., Wang, D. Q.-H., Sperandio, M., & Di Ciaula, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031105 · Cited by 969
The Health Benefits of Dietary Fibre
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2020) · Nutrients · doi:10.3390/nu12103209 · Cited by 892 · cited 1×
“Conversely, metabolic health and reduced risks for chronic diseases, including obesity, T2DM, and cardiovascular disease, have been associated with fiber intake [239,240].”
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“A meta-analysis confirmed that Lactobacillus rhamnosus GG, Saccharomyces boulardii , and probiotic mixtures can reduce antibiotic-associated and traveler’s diarrhea [142].”
Dietary protein recommendations and the prevention of sarcopenia
Paddon-Jones, D., & Rasmussen, B. B. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831cef8b · Cited by 823 · cited 1×
“Protein intake exerts multiple physiological effects relevant to obesity management, including greater satiety than carbohydrate or fat, enhanced thermogenesis, and preservation of fat-free mass through stimulation of muscle anabolism [259].”
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
GIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
Glutamine and the preservation of gut integrity
van der Hulst, R. R. W. J., von Meyenfeldt, M. F., Deutz, N. E. P., Soeters, P. B., Brummer, R. J. M., von Kreel, B. K., & Arends, J. W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90939-e · Cited by 657
Yao, H., Zhang, A., Li, D., Wu, Y., Wang, C.-Z., Wan, J.-Y., & Yuan, C.-S. (2024) · BMJ · doi:10.1136/bmj-2023-076410 · Cited by 558
SILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., & GIBSON, G. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03911.x · Cited by 551
Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses
Veronese, N., Solmi, M., Caruso, M. G., Giannelli, G., Osella, A. R., Evangelou, E., Maggi, S., Fontana, L., Stubbs, B., & Tzoulaki, I. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx082 · Cited by 536
Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia
Kim, Y.-M., Jeong, Y.-K., Wang, M.-H., Lee, W.-Y., & Rhee, H.-I. (2005) · Nutrition · doi:10.1016/j.nut.2004.10.014 · Cited by 531
Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review
Ranasinghe, P., Pigera, S., Premakumara, G. S., Galappaththy, P., Constantine, G. R., & Katulanda, P. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-275 · Cited by 483
Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G., & Gibson, G. R. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26242 · Cited by 451 · cited 1×
“Although not tested with GLP-1RAs, GOS consistently increases Bifidobacterium and Lactobacillus , while reducing potentially pathogenic bacteria such as Bacteroides spp., Clostridium perfringens , Escherichia coli , Prevotella , and Gardnerella [135–138].”
CODEX-aligned dietary fiber definitions help to bridge the ‘fiber gap’
Jones, J. M. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-34 · Cited by 422 · cited 1×
“Dietary fibers are carbohydrates that are neither digested nor absorbed in the small intestine and have a polymeric structure [237].”
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Samms, R. J., Coghlan, M. P., & Sloop, K. W. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.006 · Cited by 419
Dietary Polyunsaturated Fatty Acids (PUFAs): Uses and Potential Health Benefits
Kapoor, B., Kapoor, D., Gautam, S., Singh, R., & Bhardwaj, S. (2021) · Current Nutrition Reports · doi:10.1007/s13668-021-00363-3 · Cited by 418
Htike, Z. Z., Zaccardi, F., Papamargaritis, D., Webb, D. R., Khunti, K., & Davies, M. J. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12849 · Cited by 416
Lifestyle modification for the management of obesity
Wadden, T. A., Butryn, M. L., & Wilson, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.051 · Cited by 406
New Horizons for the Study of Dietary Fiber and Health: A Review
Fuller, S., Beck, E., Salman, H., & Tapsell, L. (2016) · Plant Foods for Human Nutrition · doi:10.1007/s11130-016-0529-6 · Cited by 395
Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies
Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15728 · Cited by 391
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383 · cited 2×
“Furthermore, long-term therapy is associated with nutritional deficiencies, lean mass loss, and frequent GI adverse events, including nausea, vomiting, diarrhea, and constipation, which may affect up to 70–85% of patients and lead to treatment discontinuation [22,38,41,60,61].”
EFSA Panel on Dietetic Products, N. A. A. (. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2815 · Cited by 370
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
Alharbi, S. H. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188231222367 · Cited by 358 · cited 1×
“[117], which could potentially complement GLP-1RA’s known reduction in inflammatory markers [345].”
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., Castro, A., Cebrián-Cuenca, A., de Torres-Sánchez, A., García-de-Lucas, M. D., Núñez, J., Obaya, J. C., Soler, M. J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010145 · Cited by 358 · cited 6×
“Furthermore, long-term therapy is associated with nutritional deficiencies, lean mass loss, and frequent GI adverse events, including nausea, vomiting, diarrhea, and constipation, which may affect up to 70–85% of patients and lead to treatment discontinuation [22,38,41,60,61].”
InfluentialOmega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update
Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-McComb, J., & Moustaid-Moussa, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.012 · Cited by 355 · cited 3×
“Taken together, omega-3 PUFA may contribute to obesity management by reducing inflammation, improving metabolic regulation, and supporting healthier body composition [187,188].”
Nutrition and Kidney Stone Disease
Siener, R. (2021) · Nutrients · doi:10.3390/nu13061917 · Cited by 355
Krill for human consumption: Nutritional value and potential health benefits
Tou, J. C., Jaczynski, J., & Chen, Y.-C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00283.x · Cited by 349
Effects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis
Jayawardena, R., Ranasinghe, P., Galappatthy, P., Malkanthi, R., Constantine, G., & Katulanda, P. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-13 · Cited by 346
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
Rodriguez, P. J., Goodwin Cartwright, B. M., Gratzl, S., Brar, R., Baker, C., Gluckman, T. J., & Stucky, N. L. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.2525 · Cited by 334 · cited 1×
“…such as gastrointestinal (GI) side effects [13,22], inadequate nutritional intake with risk of micronutrient deficiency [22], hair loss and fatigue [13], as well as potential loss of muscle mass and bone density [23] contribute to high rates of discontinuation and subsequent weight regain [24–26].”
Kumar, M., Tomar, M., Amarowicz, R., Saurabh, V., Nair, M. S., Maheshwari, C., Sasi, M., Prajapati, U., Hasan, M., Singh, S., et al. (2021) · Foods · doi:10.3390/foods10040752 · Cited by 334
Rodriguez, P. J., Goodwin Cartwright, B. M., Gratzl, S., Brar, R., Baker, C., Gluckman, T. J., & Stucky, N. L. (2023) · doi:10.1101/2023.11.21.23298775 · Cited by 334
Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity
Sergeev, I. N., Aljutaily, T., Walton, G., & Huarte, E. (2020) · Nutrients · doi:10.3390/nu12010222 · Cited by 331 · cited 1×
“Another relevant prebiotic soluble fiber is galacto-oligosaccharide (GOS), which selectively stimulates beneficial bacteria such as Bifidobacterium [135,136].”
Omega-3 Polyunsaturated Fatty Acids: Benefits and Endpoints in Sport
Gammone, M. A., Riccioni, G., Parrinello, G., & D’Orazio, N. (2018) · Nutrients · doi:10.3390/nu11010046 · Cited by 326 · cited 1×
“Beyond metabolic benefits, omega-3 PUFAs may contribute to skeletal muscle protection, protein synthesis, strength, physical performance, and immune function following intense exercise [189–192], though evidence is mixed.”
Scientific Opinion on Dietary Reference Values for zinc
EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3844 · Cited by 322
Role of zinc in health and disease
Stiles, L. I., Ferrao, K., & Mehta, K. J. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01302-6 · Cited by 275 · cited 1×
“It is present in all tissues and plays a pivotal role in several cellular processes, including protein synthesis, nucleic acid metabolism, gene transcription, cell proliferation, differentiation, and mitosis [287,288].”
Zdzieblik, D., Oesser, S., Baumstark, M. W., Gollhofer, A., & König, D. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515002810 · Cited by 269 · cited 2×
“Supplementation with 15 g/day for 12 weeks, combined with exercise, increased fat-free mass and muscle strength and reduced fat mass in elderly sarcopenic men [164] and premenopausal women [165].”
Depeint, F., Tzortzis, G., Vulevic, J., I'Anson, K., & Gibson, G. R. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.785 · Cited by 268
Scientific Opinion on Dietary Reference Values for chromium
EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3845 · Cited by 266
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu, Q. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431292 · Cited by 265 · cited 1×
“GIP, an incretin hormone secreted by K-cells of the upper small intestine, complements GLP-1 in stimulating glucose-dependent insulin release, while also contributing to adipose tissue regulation [42–45].”
Risk assessment for the amino acids taurine, l-glutamine and l-arginine
Shao, A., & Hathcock, J. N. (2008) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2008.01.004 · Cited by 265
Bovine Colostrum: Its Constituents and Uses
Playford, R. J., & Weiser, M. J. (2021) · Nutrients · doi:10.3390/nu13010265 · Cited by 265
Liu, L., Chen, J., Wang, L., Chen, C., & Chen, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1043789 · Cited by 258
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
D’Angelo, S., Motti, M. L., & Meccariello, R. (2020) · Nutrients · doi:10.3390/nu12092751 · Cited by 250 · cited 2×
“Omega-3 PUFAs also reduce hepatic very-low-density lipoprotein (VLDL) and modulate cholesteryl ester transfer protein-mediated lipid exchanges, lead-Obesities ing to increased high-density lipoprotein (HDL) and potentially higher apolipoprotein A-1 [186–188].”
Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity
Maselli, D. B., & Camilleri, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_496 · Cited by 248
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level
King, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.5.502 · Cited by 241
Wharton, S., Davies, M., Dicker, D., Lingvay, I., Mosenzon, O., Rubino, D. M., & Pedersen, S. D. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2021.2002616 · Cited by 236 · cited 1×
“Additionally, dietary fiber supplementation is a key strategy in managing GI symptoms and may help both diarrhea and constipation associated with GLP-1RAs [245,246].”
Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice
Kang, J.-H., Yun, S.-I., Park, M.-H., Park, J.-H., Jeong, S.-Y., & Park, H.-O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054617 · Cited by 230
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis
Mulvihill, E. E., Burke, A. C., & Huff, M. W. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050718 · Cited by 228
Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects
Hlebowicz, J., Darwiche, G., Björgell, O., & Almér, L.-O. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.6.1552 · Cited by 228
Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials
Anh, N. H., Kim, S. J., Long, N. P., Min, J. E., Yoon, Y. C., Lee, E. G., Kim, M., Kim, T. J., Yang, Y. Y., Son, E. Y., et al. (2020) · Nutrients · doi:10.3390/nu12010157 · Cited by 227 · cited 1×
“It has been shown to lower blood pressure, body weight, blood glucose, lipid levels (VLDL and LDL), and atherosclerotic plaques, with no serious adverse effects [351,352].”
Zinc Toxicity: Understanding the Limits
Schoofs, H., Schmit, J., & Rink, L. (2024) · Molecules · doi:10.3390/molecules29133130 · Cited by 226
Willoughby, D., Hewlings, S., & Kalman, D. (2018) · Nutrients · doi:10.3390/nu10121876 · Cited by 221 · cited 3×
“Weight loss is frequently accompanied by lean mass reductions, accounting for 15–40% of total loss, primarily from skeletal muscle, while fat mass contributes 60–85% [261,262].”
Qin, B., Panickar, K. S., & Anderson, R. A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400324 · Cited by 220 · cited 1×
“Additionally, its anti-inflammatory and antioxidant properties may alleviate obesity-related inflammation, potentially amplifying the pro-insulinotropic and β -cell protective effects of GLP-1 [204,324,325].”
Islam, S. U. (2016) · Medicine · doi:10.1097/md.0000000000002658 · Cited by 219
The effect of psyllium husk on intestinal microbiota in constipated patients and healthy controls
Jalanka, J., Major, G., Murray, K., Singh, G., Nowak, A., Kurtz, C., Silos-Santiago, I., Johnston, J. M., de Vos, W. M., & Spiller, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020433 · Cited by 219
GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes
Do, D., Lee, T., Peasah, S. K., Good, C. B., Inneh, A., & Patel, U. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.13172 · Cited by 218 · cited 1×
“…such as gastrointestinal (GI) side effects [13,22], inadequate nutritional intake with risk of micronutrient deficiency [22], hair loss and fatigue [13], as well as potential loss of muscle mass and bone density [23] contribute to high rates of discontinuation and subsequent weight regain [24–26].”
Obesity and sleep disturbance: The chicken or the egg?
Muscogiuri, G., Barrea, L., Annunziata, G., Di Somma, C., Laudisio, D., Colao, A., & Savastano, S. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1506979 · Cited by 214
Lai, H., Li, Y., He, Y., Chen, F., Mi, B., Li, J., Xie, J., Ma, G., Yang, J., Xu, K., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2197837 · Cited by 208 · cited 2×
“Outside the enteral nutrition setting, psyllium has demonstrated mechanisms relevant to GLP-1RA-related GI adverse events, including constipation and irritable bowel syndrome (IBS) [64,250,251].”
Wong, H. J., Sim, B., Teo, Y. H., Teo, Y. N., Chan, M. Y., Yeo, L. L. L., Eng, P. C., Tan, B. Y. Q., Sattar, N., Dalakoti, M., et al. (2025) · Diabetes Care · doi:10.2337/dc24-1678 · Cited by 208
Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review
Chavda, V. P., Ajabiya, J., Teli, D., Bojarska, J., & Apostolopoulos, V. (2022) · Molecules · doi:10.3390/molecules27134315 · Cited by 208
Zhao, C., Yang, C., Wai, S. T. C., Zhang, Y., P. Portillo, M., Paoli, P., Wu, Y., San Cheang, W., Liu, B., Carpéné, C., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1501658 · Cited by 199
Zhou, Q., Verne, M. L., Fields, J. Z., Lefante, J. J., Basra, S., Salameh, H., & Verne, G. N. (2019) · Gut · doi:10.1136/gutjnl-2017-315136 · Cited by 195
Zare, R., Nadjarzadeh, A., Zarshenas, M. M., Shams, M., & Heydari, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.03.003 · Cited by 188 · cited 3×
“…T2DM patients showed that 3 months of cinnamon (1 g/day) decreased fasting and postprandial glucose, HbA1c, fasting insulin, insulin resistance, body weight, BMI, body fat (including visceral fat), and improved cholesterol profiles, with greater benefits in overweight individuals (BMI ≥ 27) [204].”
InfluentialChang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S., Greer, K. B., Hanson, B., Harris, L. A., Ko, C., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.214 · Cited by 185
Lozoya, X., Reyes-Morales, H., Chávez-Soto, M. A., Martı́nez-Garcı́a, M. D. C., Soto-González, Y., & Doubova, S. V. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00185-x · Cited by 183
Kim, J., Yun, J. M., Kim, M. K., Kwon, O., & Cho, B. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.3937 · Cited by 182
Ranasinghe, P., Jayawardana, R., Galappaththy, P., Constantine, G. R., de Vas Gunawardana, N., & Katulanda, P. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03718.x · Cited by 176
Drakoularakou, A., Tzortzis, G., Rastall, R. A., & Gibson, G. R. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.120 · Cited by 174 · cited 2×
“This favorable tolerability profile is attributed to its selective fermentation by Bifidobacterium , which does not produce gas as a metabolic byproduct [137,139].”
Diets and drugs for weight loss and health in obesity – An update
Aaseth, J., Ellefsen, S., Alehagen, U., Sundfør, T. M., & Alexander, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111789 · Cited by 174
Effects of probiotics on type II diabetes mellitus: A meta-analysis
Tao, Y.-W., Gu, Y.-L., Mao, X.-Q., Zhang, L., & Pei, Y.-F. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02213-2 · Cited by 173
Yun, S. I., Park, H. O., & Kang, J. H. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04350.x · Cited by 173
Gleason, P. P., Urick, B. Y., Marshall, L. Z., Friedlander, N., Qiu, Y., & Leslie, R. S. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.23332 · Cited by 172
Adisakwattana, S., Lerdsuwankij, O., Poputtachai, U., Minipun, A., & Suparpprom, C. (2011) · Plant Foods for Human Nutrition · doi:10.1007/s11130-011-0226-4 · Cited by 171
Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract
Deguchi, Y., & Miyazaki, K. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-9 · Cited by 170
FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance
Szczepańska, E., & Gietka‐Czernel, M. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1778-4159 · Cited by 170
Mohamed Sham Shihabudeen, H., Hansi Priscilla, D., & Thirumurugan, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-46 · Cited by 163
Chen, L., Liu, B., Ren, L., Du, H., Fei, C., Qian, C., Li, B., Zhang, R., Liu, H., Li, Z., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1069954 · Cited by 155 · cited 1×
“In more recent trials with T2DM and prediabetic patients, fiber consumption was associated with reduced HbA1c and fasting glucose, increased microbiota diversity, and elevated insulin and C-peptide levels [127,128].”
Suksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12147 · Cited by 154
Blood orange juice inhibits fat accumulation in mice
Titta, L., Trinei, M., Stendardo, M., Berniakovich, I., Petroni, K., Tonelli, C., Riso, P., Porrini, M., Minucci, S., Pelicci, P. G., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.266 · Cited by 145
Christoffersen, B. Ø., Sanchez‐Delgado, G., John, L. M., Ryan, D. H., Raun, K., & Ravussin, E. (2022) · Obesity · doi:10.1002/oby.23374 · Cited by 142 · cited 2×
“Weight loss is frequently accompanied by lean mass reductions, accounting for 15–40% of total loss, primarily from skeletal muscle, while fat mass contributes 60–85% [261,262].”
Huang, Y.-H., Chiu, W.-C., Hsu, Y.-P., Lo, Y.-L., & Wang, Y.-H. (2020) · Nutrients · doi:10.3390/nu12123739 · Cited by 142 · cited 1×
“In older adults, >2 g/day was associated with modest gains in muscle mass (0.67 kg) and improvements in walking speed, particularly after interventions > 6 months (1.78 m/s; 95% CI: 1.38–2.17) [190].”
InfluentialPLAYFORD, R. J., MACDONALD, C. E., CALNAN, D. P., FLOYD, D. N., PODAS, T., JOHNSON, W., WICKS, A. C., BASHIR, O., & MARCHBANK, T. (2001) · Clinical Science · doi:10.1042/cs1000627 · Cited by 141
Jung, S.-P., Lee, K.-M., Kang, J.-H., Yun, S.-I., Park, H.-O., Moon, Y., & Kim, J.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.2.80 · Cited by 140
Shabbir, H., Kausar, T., Noreen, S., Rehman, H. U., Hussain, A., Huang, Q., Gani, A., Su, S., & Nawaz, A. (2020) · Animals · doi:10.3390/ani10091714 · Cited by 140
Welsh, P., Polisecki, E., Robertson, M., Jahn, S., Buckley, B. M., de Craen, A. J. M., Ford, I., Jukema, J. W., Macfarlane, P. W., Packard, C. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1064 · Cited by 140
Schäfer, A., & Högger, P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.011 · Cited by 136
Kang, J.-H., Yun, S.-I., & Park, H.-O. (2010) · The Journal of Microbiology · doi:10.1007/s12275-010-0363-8 · Cited by 135
Ojo, O., Feng, Q.-Q., Ojo, O. O., & Wang, X.-H. (2020) · Nutrients · doi:10.3390/nu12113239 · Cited by 134 · cited 3×
“A meta-analysis of nine T2DM studies demonstrated that fiber supplementation improves HbA1c, increases total SCFAs, and enhances Bifidobacterium abundance, supporting systemic metabolic benefits [126].”
InfluentialPartula, V., Deschasaux, M., Druesne-Pecollo, N., Latino-Martel, P., Desmetz, E., Chazelas, E., Kesse-Guyot, E., Julia, C., Fezeu, L. K., Galan, P., et al. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa063 · Cited by 133
van Zuylen, M. L., Siegelaar, S. E., Plummer, M. P., Deane, A. M., Hermanides, J., & Hulst, A. H. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.01.001 · Cited by 132 · cited 1×
“In the GI tract, GLP-1 acts on myoenteric neurons and inhibits vagal activity, thereby delaying gastric emptying and lowering gastric acid secretion, which further promotes satiety and reduces caloric intake [38,39].”
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Bu, T., Sun, Z., Pan, Y., Deng, X., & Yuan, G. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0277 · Cited by 131
Xie, Y., Gou, L., Peng, M., Zheng, J., & Chen, L. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.032 · Cited by 130
Ryan, P. M., Seltzer, S., Hayward, N. E., Rodriguez, D. A., Sless, R. T., & Hawkes, C. P. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.05.009 · Cited by 129
Protein, amino acids and obesity treatment
Simonson, M., Boirie, Y., & Guillet, C. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09574-5 · Cited by 128
Chronic Constipation: Is a Nutritional Approach Reasonable?
Bellini, M., Tonarelli, S., Barracca, F., Rettura, F., Pancetti, A., Ceccarelli, L., Ricchiuti, A., Costa, F., de Bortoli, N., Marchi, S., et al. (2021) · Nutrients · doi:10.3390/nu13103386 · Cited by 128
Effects of ginger on gastric emptying and motility in healthy humans
Wu, K.-L., Rayner, C. K., Chuah, S.-K., Changchien, C.-S., Lu, S.-N., Chiu, Y.-C., Chiu, K.-W., & Lee, C.-M. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f4b224 · Cited by 126 · cited 1×
“In a randomized, double-blind study with 24 healthy adults, 1.2 g of oral ginger accelerated gastric emptying (half-emptying time after a meal 13 min vs. 27 min with placebo), and increased gastric antral contractions without adverse symptoms [350].”
InfluentialKabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
Shen, Y., FUKUSHIMA, M., Ito, Y., Muraki, E., Hosono, T., Seki, T., & ARIGA, T. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.100453 · Cited by 126
Cinnamon in glycaemic control: Systematic review and meta analysis
Akilen, R., Tsiami, A., Devendra, D., & Robinson, N. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.04.003 · Cited by 124 · cited 3×
“Moreover, two meta-analyses of clinical trials reported that it can positively affect obesity measures (body weight, BMI, body fat, and waist circumference), lower fasting plasma glucose, and improve lipid parameters [202,203].”
InfluentialLiu, X., Wei, J., Tan, F., Zhou, S., Würthwein, G., & Rohdewald, P. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.043 · Cited by 124
Mitra, A., Mahalanabis, D., Ashraf, H., Unicomb, L., Eeckels, R., & Tzipori, S. (1995) · Acta Paediatrica · doi:10.1111/j.1651-2227.1995.tb13814.x · Cited by 123
Alam, M. A., Uddin, R., Subhan, N., Rahman, M. M., Jain, P., & Reza, H. M. (2015) · Journal of Lipids · doi:10.1155/2015/496169 · Cited by 123 · cited 3×
“Bitter melon ( Momordica charantia ) Clinical (RCTs and meta-analyses), preclinical ↑ GLP-1 and insulin; ↓ fasting glucose, HbA1c, TC, TG, LDL, and weight [193–201].”
Wang, X., Valenzano, M. C., Mercado, J. M., Zurbach, E. P., & Mullin, J. M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2328-8 · Cited by 121
Cellular chromium enhances activation of insulin receptor kinase
Wang, H., Kruszewski, A., & Brautigan, D. L. (2005) · Biochemistry · doi:10.1021/bi0473152 · Cited by 121 · cited 1×
“It enhances insulin signaling by upregulating receptor kinase activity, thereby improving glycemic control [284].”
van der Schoot, A., Drysdale, C., Whelan, K., & Dimidi, E. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac184 · Cited by 120 · cited 2×
“A meta-analysis of 16 randomized controlled trials with 1251 adults with chronic constipation showed that fiber, particularly psyllium at doses >10 g/day for ≥ 4 weeks, significantly improved stool frequency and consistency [132].”
Sharma, S., Agrawal, R. P., Choudhary, M., Jain, S., Goyal, S., & Agarwal, V. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.03.003 · Cited by 120 · cited 2×
“Improvements in insulin sensitivity and glycemic control [174–176] could potentiate GLP-1RA efficacy, although chromium’s role may be sup-Obesities portive rather than primary.”
Mazhar, M., Zhu, Y., & Qin, L. (2023) · Foods · doi:10.3390/foods12051023 · Cited by 119 · cited 1×
“SCFAs can stimulate GLP-1 and peptide YY (PYY) secretion by L-cells and leptin release by adipose tissue, while reduced SCFAs production is linked to T2DM’s pathophysiology [130,242].”
Holwerda, A. M., & van Loon, L. J. C. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab083 · Cited by 117 · cited 1×
“Protein stimulates muscle protein synthesis by providing both anabolic signaling and amino acid precursors [265].”
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients · doi:10.3390/nu13082748 · Cited by 116
Miyoshi, Y., Tanabe, S., & Suzuki, T. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00405.2015 · Cited by 115 · cited 1×
“Zinc strengthens tight junctions through regulation of occludin proteolysis and claudin-3 transcription [290], increases mucus production, and reduces gastric acid secretion [184,291,292], while also promoting wound healing [293].”
Sartorius, T., Peter, A., Schulz, N., Drescher, A., Bergheim, I., Machann, J., Schick, F., Siegel-Axel, D. I., Schürmann, A., Weigert, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092358 · Cited by 115
Horn, D. B., Almandoz, J. P., & Look, M. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2051366 · Cited by 114 · cited 1×
“Several anti-obesity drugs have been shown to promote weight loss, including orlistat, phentermine, phentermine–topiramate, naltrexone–bupropion, and glucagon-like peptide-1 receptor agonists (GLP-1RAs) [14,15].”
Antidiarrhoeal activity of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract in rodents
Ojewole, J. A. O., Awe, E. O., & Chiwororo, W. D. H. (2008) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.44.195 · Cited by 114
Ansari, H. U. H., Qazi, S. U., Sajid, F., Altaf, Z., Ghazanfar, S., Naveed, N., Ashfaq, A. S., Siddiqui, A. H., Iqbal, H., & Qazi, S. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2023.11.007 · Cited by 112
GLP‐1 agonists for obesity and type 2 diabetes in children: Systematic review and meta‐analysis
Chadda, K. R., Cheng, T. S., & Ong, K. K. (2020) · Obesity Reviews · doi:10.1111/obr.13177 · Cited by 111
Samad, M. B., Mohsin, M. N. A. B., Razu, B. A., Hossain, M. T., Mahzabeen, S., Unnoor, N., Muna, I. A., Akhter, F., Kabir, A. U., & Hannan, J. M. A. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1903-0 · Cited by 109
Christensen, S., Robinson, K., Thomas, S., & Williams, D. R. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100121 · Cited by 108 · cited 1×
“…and more recently dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RAs such as tirzepatide, show robust efficacy, not only for weight reduction but also in glycemic control and cardiovascular risk reduction [13,16], achieving placebo-adjusted weight loss of 8–21% after one year [17–19].”
Momordica charantia: A popular health-promoting vegetable with multifunctionality
Wang, S., Li, Z., Yang, G., Ho, C.-T., & Li, S. (2017) · Food & Function · doi:10.1039/c6fo01812b · Cited by 104
Unravelling the Biological Potential of Pinus pinaster Bark Extracts
Ferreira-Santos, P., Genisheva, Z., Botelho, C., Santos, J., Ramos, C., Teixeira, J. A., & Rocha, C. M. R. (2020) · Antioxidants · doi:10.3390/antiox9040334 · Cited by 104 · cited 1×
“Pine bark extract also inhibits α -amylase and α -glucosidase, supporting its glucose-lowering effects [217–219].”
Zhang, Y. Y., Liu, W., Zhao, T. Y., & Tian, H. M. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0755-5 · Cited by 101 · cited 2×
“A meta-analysis of 11 RCTs ( n = 617) reported decreases in waist circumference and triglycerides in overweight/obese adults [187].”
Maharlouei, N., Tabrizi, R., Lankarani, K. B., Rezaianzadeh, A., Akbari, M., Kolahdooz, F., Rahimi, M., Keneshlou, F., & Asemi, Z. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1427044 · Cited by 99 · cited 2×
“…confirmed benefits, especially in T2DM and overweight/obese individuals, with improvements in fasting glucose, HbA1c, insulin resistance (HOMA-IR), and systolic and diastolic blood pressure, though effects on total cholesterol, LDL, and triglycerides were mostly nonsignificant [235,236].”
Beejmohun, V., Peytavy-Izard, M., Mignon, C., Muscente-Paque, D., Deplanque, X., Ripoll, C., & Chapal, N. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-351 · Cited by 97 · cited 2×
“Continued use after GLP-1RA discontinuation might help maintain glycemic control and mitigate rebound hyperglycemia or weight regain [110,202–204, 321, 3.5.3.”
InfluentialPompano, L. M., & Boy, E. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa087 · Cited by 97 · cited 2×
“…a meta-analysis reported that modest increases in zinc intake (9.2–25 mg/day) over longer durations ( ≥ 12 weeks) were associated with improvements in insulin resistance, fasting glycemia, LDL-c, total cholesterol, and triglycerides, both in healthy and metabolically impaired populations [181].”
InfluentialA systematic review of the effect of semaglutide on lean mass: insights from clinical trials
Bikou, A., Dermiki-Gkana, F., Penteris, M., Constantinides, T. K., & Kontogiorgis, C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2343092 · Cited by 97
Oertzen-Hagemann, V., Kirmse, M., Eggers, B., Pfeiffer, K., Marcus, K., de Marées, M., & Platen, P. (2019) · Nutrients · doi:10.3390/nu11051072 · Cited by 97
Peter, E. L., Kasali, F. M., Deyno, S., Mtewa, A., Nagendrappa, P. B., Tolo, C. U., Ogwang, P. E., & Sesaazi, D. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.10.033 · Cited by 96
Mansour, M. S., Ni, Y.-M., Roberts, A. L., Kelleman, M., RoyChoudhury, A., & St-Onge, M.-P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.016 · Cited by 96
Probiotics: Should All Patients Take Them?
Katkowska, M., Garbacz, K., & Kusiak, A. (2021) · Microorganisms · doi:10.3390/microorganisms9122620 · Cited by 92
Krieger, J.-P. (2020) · Peptides · doi:10.1016/j.peptides.2020.170342 · Cited by 91
Antonio, J., Sanders, M. S., & Van Gammeren, D. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00552-9 · Cited by 88 · cited 1×
“In healthy adults performing exercise, 8 weeks of colostrum increased lean mass and improved body composition compared to WP [171], suggesting potential to counteract GLP-1RA-induced muscle loss through muscle protein synthesis.”
Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease
Yusuf, K., Saha, S., & Umar, S. (2022) · Biomedicines · doi:10.3390/biomedicines10061242 · Cited by 88
Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans
NISHIOKA, K., HIDAKA, T., NAKAMURA, S., UMEMURA, T., JITSUIKI, D., SOGA, J., GOTO, C., CHAYAMA, K., YOSHIZUMI, M., & HIGASHI, Y. (2007) · Hypertension Research · doi:10.1291/hypres.30.775 · Cited by 85 · cited 1×
“Mechanistically, as clinically demonstrated, pine bark’s bioflavonoids activate endothelial nitric oxide synthase (eNOS), increasing nitric oxide (NO)-mediated vasodilation and overall cardiovascular health [216].”
Chao, A. M., Wadden, T. A., Walsh, O. A., Gruber, K. A., Alamuddin, N., Berkowitz, R. I., & Tronieri, J. S. (2019) · Obesity · doi:10.1002/oby.22653 · Cited by 84
Cheang, J. Y., & Moyle, P. M. (2018) · ChemMedChem · doi:10.1002/cmdc.201700781 · Cited by 82
Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health
Rodriguez, D., Lavie, C. J., Elagizi, A., & Milani, R. V. (2022) · Nutrients · doi:10.3390/nu14235146 · Cited by 81 · cited 1×
“High intake of PUFAs eicosapentaenoic acid (EPA) and docosa-hexaenoic acid (DHA) has been associated with various health benefits [296] and may potentially complement GLP-1RA therapy by exerting multiple molecular mechanisms that modulate adipose tissue, inflammation, and energy metabolism;…”
Walstab, J., Krüger, D., Stark, T., Hofmann, T., Demir, I. E., Ceyhan, G. O., Feistel, B., Schemann, M., & Niesler, B. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12107 · Cited by 81
DEGUCHI, Y., OSADA, K., UCHIDA, K., KIMURA, H., YOSHIKAWA, M., KUDO, T., YASUI, H., & WATANUKI, M. (1998) · Journal of the agricultural chemical society of Japan · doi:10.1271/nogeikagaku1924.72.923 · Cited by 80
Kim, S. K., Jung, J., Jung, J. H., Yoon, N., Kang, S. S., Roh, G. S., & Hahm, J. R. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102524 · Cited by 79 · cited 1×
“These improvements in glucose homeostasis were confirmed by a later meta-analysis of 10 studies (1045 T2DM patients) [198] and several more recent trials in prediabetic and diabetic individuals [195–197].”
Zhu, X., Ouyang, W., Lan, Y., Xiao, H., Tang, L., Liu, G., Feng, K., Zhang, L., Song, M., & Cao, Y. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100574 · Cited by 79
Cardile, V., Graziano, A. C. E., & Venditti, A. (2015) · Natural Product Research · doi:10.1080/14786419.2014.1000897 · Cited by 78
Hansen, T. T., Astrup, A., & Sjödin, A. (2021) · Nutrients · doi:10.3390/nu13093193 · Cited by 77 · cited 1×
“A meta-analysis of 37 randomized controlled trials confirmed that higher protein intake reduced body weight by ~1.6 kg, with prediabetic subjects benefiting the most [163].”
InfluentialZinc and Diabetes: A Connection between Micronutrient and Metabolism
Ahmad, R., Shaju, R., Atfi, A., & Razzaque, M. S. (2024) · Cells · doi:10.3390/cells13161359 · Cited by 77
GLP-1 agonists for obesity—A new recipe for success
Mozaffarian, D. (2024) · JAMA · doi:10.1001/jama.2024.2252 · Cited by 76
Cava, E., Padua, E., Campaci, D., Bernardi, M., Muthanna, F. M. S., Caprio, M., & Lombardo, M. (2024) · Healthcare · doi:10.3390/healthcare12020246 · Cited by 74
Wang, T., Zhang, X., Zhou, N., Shen, Y., Li, B., Chen, B. E., & Li, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029512 · Cited by 73 · cited 1×
“…( n = 72,598) demonstrated a dose-response relationship between omega-3 intake and reductions in triglycerides and non-HDL cholesterol, particularly in hyperlipidemia, overweight/obesity, or coronary heart disease, and more evident with doses >2 g/day or in those on lipid-lowering therapy [299].”
Van den Abbeele, P., Verstrepen, L., Ghyselinck, J., Albers, R., Marzorati, M., & Mercenier, A. (2020) · Nutrients · doi:10.3390/nu12071917 · Cited by 73 · cited 3×
“These metabolites strengthen the intestinal epithelial barrier, reduce inflammation, and reduce diarrhea risk [133].”
Ranasinghe, P. D., Jayawardena, R., Pigera, S., Wathurapatha, W. S., Weeratunge, H. D., Premakumara, G. A. S., Katulanda, P., Constantine, G. R., & Galappaththy, P. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2067-7 · Cited by 72
Jendricke, P., Centner, C., Zdzieblik, D., Gollhofer, A., & König, D. (2019) · Nutrients · doi:10.3390/nu11040892 · Cited by 70 · cited 1×
“Supplementation with 15 g/day for 12 weeks, combined with exercise, increased fat-free mass and muscle strength and reduced fat mass in elderly sarcopenic men [164] and premenopausal women [165].”
Mousavi, S. M., Rahmani, J., Kord-Varkaneh, H., Sheikhi, A., Larijani, B., & Esmaillzadeh, A. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.02.017 · Cited by 69 · cited 1×
“Moreover, two meta-analyses of clinical trials reported that it can positively affect obesity measures (body weight, BMI, body fat, and waist circumference), lower fasting plasma glucose, and improve lipid parameters [202,203].”
Vinayagam, R., Jayachandran, M., Chung, S. S. M., & Xu, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.127 · Cited by 66
Pérez‐Jiménez, J. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.138076 · Cited by 66
The Role of Momordica charantia in Resisting Obesity
Fan, M., Kim, E.-K., Choi, Y.-J., Tang, Y., & Moon, S.-H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16183251 · Cited by 65
Li, M.-L., Zhang, F., Luo, H.-Y., Quan, Z.-W., Wang, Y.-F., Huang, L.-T., & Wang, J.-H. (2024) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100184 · Cited by 62
Veronese, N., Gianfredi, V., Solmi, M., Barbagallo, M., Dominguez, L. J., Mandalà, C., Palermo, C. D., Carruba, L., Solimando, L., Stubbs, B., et al. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.06.021 · Cited by 61
Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms
Kato, S., Sato, T., Fujita, H., Kawatani, M., & Yamada, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-88612-x · Cited by 59
Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd
Huang, T.-N., Lu, K.-N., Pai, Y.-P., Hsu, C., & Huang, C. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/625892 · Cited by 59
Guo, X., Zhou, Z., Lyu, X., Xu, H., Zhu, H., Pan, H., Wang, L., Yang, H., & Gong, F. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1844-1176 · Cited by 59 · cited 1×
“Among individuals with overweight or obesity, with or without diabetes, GLP-1RA therapy results in significant weight reduction compared with placebo [50–52].”
Hirudkar, J. R., Parmar, K. M., Prasad, R. S., Sinha, S. K., Jogi, M. S., Itankar, P. R., & Prasad, S. K. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103807 · Cited by 58
Talagavadi, V., Rapisarda, P., Galvano, F., Pelicci, P., & Giorgio, M. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2015.12.007 · Cited by 57
Effects of bovine colostrum on recurrent respiratory tract infections and diarrhea in children
Saad, K., Abo-Elela, M. G. M., El-Baseer, K. A. A., Ahmed, A. E., Ahmad, F.-A., Tawfeek, M. S. K., El-Houfey, A. A., Aboul_Khair, M. D., Abdel-Salam, A. M., Abo-elgheit, A., et al. (2016) · Medicine · doi:10.1097/md.0000000000004560 · Cited by 57 · cited 1×
“Supplementation prevented the increase in intestinal permeability caused by non-steroidal anti-inflammatory drugs (NSAIDs) [168]; reduced the incidence, duration, and severity of pediatric infectious diarrhea [277–281]; and ameliorated gut dysfunction in malnutrition [282].”
Ranasinghe, P., Galappaththy, P., Constantine, G. R., Jayawardena, R., Weeratunga, H. D., Premakumara, S., & Katulanda, P. (2017) · Trials · doi:10.1186/s13063-017-2192-0 · Cited by 57
Cuyul-Vásquez, I., Pezo-Navarrete, J., Vargas-Arriagada, C., Ortega-Díaz, C., Sepúlveda-Loyola, W., Hirabara, S. M., & Marzuca-Nassr, G. N. (2023) · Nutrients · doi:10.3390/nu15153424 · Cited by 56
Alkhedhairi, S. A., Aba Alkhayl, F. F., Ismail, A. D., Rozendaal, A., German, M., MacLean, B., Johnston, L., Miller, A. A., Hunter, A. M., Macgregor, L. J., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.04.007 · Cited by 56
Effects of Chromium Picolinate on Food Intake and Satiety
Anton, S. D., Morrison, C. D., Cefalu, W. T., Martin, C. K., Coulon, S., Geiselman, P., Han, H., White, C. L., & Williamson, D. A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0292 · Cited by 54 · cited 3×
“Chromium may also influence appetite: in a placebo-controlled trial of overweight women with cravings, 1 mg/day of chromium picolinate for 8 weeks reduced daily food intake, hunger, and cravings for fats, although weight reduction was not significant ( p = 0.08) [173].”
InfluentialGu, D.-T., Tung, T.-H., Jiesisibieke, Z. L., Chien, C.-W., & Liu, W.-Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.790901 · Cited by 54
Tella, T., Masola, B., & Mukaratirwa, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.137 · Cited by 54
Semaglutide Eligibility Across All Current Indications for US Adults
Shi, I., Khan, S. S., Yeh, R. W., Ho, J. E., Dahabreh, I. J., & Kazi, D. S. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2024.4657 · Cited by 53
Kirmse, M., Oertzen-Hagemann, V., de Marées, M., Bloch, W., & Platen, P. (2019) · Nutrients · doi:10.3390/nu11051154 · Cited by 53
Choi, J., Lee, J., Kim, K., Choi, H.-K., Lee, S.-A., & Lee, H.-J. (2022) · Nutrients · doi:10.3390/nu14234982 · Cited by 53 · cited 1×
“Two meta-analyses also showed benefits in postoperative nausea [232] and acute chemotherapy-induced vomiting [233].”
Hu, Y., Amoah, A. N., Zhang, H., Fu, R., Qiu, Y., Cao, Y., Sun, Y., Chen, H., Liu, Y., & Lyu, Q. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1712714 · Cited by 53
Berge, R. K., Ramsvik, M. S., Bohov, P., Svardal, A., Nordrehaug, J. E., Rostrup, E., Bruheim, I., & Bjørndal, B. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0162-7 · Cited by 51
The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis
Xiao, Y., Zhang, Q., Liao, X., Elbelt, U., & Weylandt, K. H. (2022) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102456 · Cited by 50
Wu, S., Jia, W., He, H., Yin, J., Xu, H., He, C., Zhang, Q., Peng, Y., & Cheng, R. (2023) · Nutrients · doi:10.3390/nu15214569 · Cited by 49 · cited 1×
“A ran-Obesities domized double-blind trial in healthy adults demonstrated that pectin-containing soluble fiber improved postprandial glycemic control likely via increased GLP-1 secretion [129].”
Therdyothin, A., Prokopidis, K., Galli, F., Witard, O. C., & Isanejad, M. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae055 · Cited by 49
The role of glutamine in supporting gut health and neuropsychiatric factors
Deters, B. J., & Saleem, M. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.02.003 · Cited by 49
Badely, M., Sepandi, M., Samadi, M., Parastouei, K., & Taghdir, M. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.11.001 · Cited by 48 · cited 1×
“WP has also been shown to improve systolic and diastolic blood pressure, waist circumference, triglycerides, cholesterol profile, fasting blood glucose, and insulin resistance in metabolic syndrome [159,160].”
Ursoniu, S., Sahebkar, A., Serban, M.-C., Antal, D., Mikhailidis, D. P., Cicero, A., Athyros, V., Rizzo, M., Rysz, J., & Banach, M. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nuw063 · Cited by 48
Amirani, E., Milajerdi, A., Reiner, Ž., Mirzaei, H., Mansournia, M. A., & Asemi, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01384-7 · Cited by 47
Lu, J., Mao, D., Li, X., Ma, Y., Luan, Y., Cao, Y., & Luan, Y. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.04.015 · Cited by 47 · cited 2×
“…animal studies suggested broad-spectrum antidiarrheal and antimicrobial benefits by restoring microbial diversity, increasing beneficial genera [212], by reducing bacterial load and virulence factors [340,341], as well as by protecting enterocytes lining from damage, necrosis, and ulceration…”
Xie, Z., Hu, J., Gu, H., Li, M., & Chen, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244432 · Cited by 47
Mazumdar, S., Akter, R., & Talukder, D. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(15)30163-5 · Cited by 47
Díaz-de-Cerio, E., Rodríguez-Nogales, A., Algieri, F., Romero, M., Verardo, V., Segura-Carretero, A., Duarte, J., & Galvez, J. (2017) · Food Research International · doi:10.1016/j.foodres.2017.03.019 · Cited by 47
Pedimune in recurrent respiratory infection and diarrhoea—The Indian experience—The pride study
Patel, K., & Rana, R. (2006) · The Indian Journal of Pediatrics · doi:10.1007/bf02759923 · Cited by 46
Van den Abbeele, P., Deyaert, S., Albers, R., Baudot, A., & Mercenier, A. (2023) · Nutrients · doi:10.3390/nu15092090 · Cited by 46 · cited 4×
“Consistent modulation has been observed across varied microbiota profiles [73,74,134].”
Influential90-Day oral (gavage) study in rats with galactooligosaccharides syrup
Anthony, J. C., Merriman, T. N., & Heimbach, J. T. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.10.012 · Cited by 46
Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity—Reply
Aronne, L. J., & SURMOUNT-4 Investigators (2024) · JAMA · doi:10.1001/jama.2024.2603 · Cited by 45
SIMÃO, A. A., MARQUES, T. R., MARCUSSI, S., & CORRÊA, A. D. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720160067 · Cited by 44
Eslamian, G., Ardehali, S. H., Baghestani, A.-R., & Vahdat Shariatpanahi, Z. (2019) · Nutrition · doi:10.1016/j.nut.2018.10.013 · Cited by 44
Rapisarda, P., Amenta, M., Ballistreri, G., Fabroni, S., & Timpanaro, N. (2022) · Molecules · doi:10.3390/molecules27248675 · Cited by 44
Research works printed but not linked: 13
- Choi, 2019, Oral Collagen Supplementation: A Systematic Review of Dermatological Applications, J. Drugs Dermatol., 18, 9
- Modi, M., and Modi, K. (2025, November 19). Ginger Root, StatPearls, Available online: https://www.ncbi.nlm.nih.gov/books/NBK565886/.
- Guarneiri, 2025, Investigation of the Influence of a Bitter Melon Product on Indicators of Cardiometabolic Health in Adults with Prediabetes, J. Am. Nutr. Assoc., 44, 306
- Deguchi, 2000, Effectiveness of consecutive ingestion and excess intake of guava leaves tea in human volunteers, J. Jpn. Council. Adv. Food Ingred. Res., 3, 19
- Giacosa, 2015, Can nausea and vomiting be treated with ginger extract?, Eur. Rev. Med. Pharmacol. Sci., 19, 1291
- Pongrojpaw, 2007, A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy, J. Med. Assoc. Thail., 90, 1703
- Dayib, 2020, Dietary fibers reduce obesity-related disorders: Mechanisms of action, Curr. Opin. Clin. Nutr. Metab. Care, 23, 445
- Barakat, 2020, Bovine Colostrum in the Treatment of Acute Diarrhea in Children: A Double-Blinded Randomized Controlled Trial, J. Trop. Pediatr., 66, 46
- Kannappan, 2006, Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat, Singap. Med. J., 47, 858
- Javed, 2012, Lipid lowering effect of Cinnamomum zeylanicum in hyperlipidaemic albino rabbits, Pak. J. Pharm. Sci., 25, 141
- Ahmad, 2025, Ameliorating implications of Psidium guajava L. (guava) leaf against metabolic syndromes—A review, J. Agric. Food Res., 21, 101867
- Amin, A.N., Intang, I.N., and Alfira, N. (2024). Effect of guajava (Psidium) leaves decoction on changes in blood glucose levels of people with diabetes mellitus. Proc. Optim., 1.
- Salaramoli, 2022, The effects of ginger and its constituents in the prevention of metabolic syndrome: A review, Iran. J. Basic Med. Sci., 25, 664
Cited by
Moscucci, F., Baratta, F., Pastori, D., Menichelli, D., Mattioli, A. V., Gallina, S., Lospinuso, I., Sciomer, S., Piccirillo, G., & Desideri, G. (2026) · Nutrients · doi:10.3390/nu18040632 · Cited by 11
“More-over, distributing protein intake evenly across meals has been found to be particularly effective, as it maximizes muscle protein synthesis throughout the day [72].”
Tjandrawinata, R. R., Rosari, B. P., Syahputra, R. A., Surya, R., & Nurkolis, F. (2026) · Nutrients · doi:10.3390/nu18030547 · Cited by 9
Dziewierz, A., & Siudak, Z. (2026) · Nutrients · doi:10.3390/nu18111761 · Cited by 3
“…to inhibit gastric emptying, reducing fat load per meal is a physiologically plausible and commonly recommended strategy to reduce postprandial nausea and fullness during GLP-1 RA titration, although randomized dietary-modification trials specifically in GLP-1-treated cohorts are lacking [66,67].”
Benito‐Vázquez, I., Rosell, M. D. L. Á., Lates-Profir, N., Díez‐Municio, M., Moreno, F. J., Frontela‐Saseta, C., & López-Nicolás, R. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107414 · Cited by 1
Beyond One-Size-Fits-All: Individually Tailored Dietary Interventions in Modern Obesity Care
Cozma-Petruț, A. P., Gherghel, M., Banc, R., Tișa, I. B., Stanciu, O., Coldea, T. E., Mudura, E., Miere, D., & Filip, L. A. (2026) · Nutrients · doi:10.3390/nu18162691 · Cited by 1
Metadata
- Authors
- Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., Menezes, C. D., Silva, I. S. T. E., & Name, J. J.
- Affiliations
- Kilyos Assessoria, Cursos e Palestras, São Paulo 01311-100, Brazil
- Corresponding author
- Name, José João
- Venue
- Obesities
- Publisher
- MDPI AG
- Published
- 2025-12-02
- Volume
- 5
- Issue
- 4
- Pages
- 88
- ISSN
- 2673-4168 (ISSN-L)
- OpenAlex
- W4417124127
- Cited by
- 8
- References
- 324
- Citations by year
- 2026: 8
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Obesities (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- GLP-1 receptor agonists, obesity, omega-3 polyunsaturated fatty acids, lean mass loss, gastrointestinal adverse effects, weight regain, probiotics and prebiotics, flavonoids, anthocyanins, high-quality protein, gut microbiota, inflammation, body composition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.